Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ABG
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | Jed Milstein SVP & CHRO | ABG Asbury Automotive Group Inc | Sale | 948 | $250.28 | $237.3K Sale | Form 4 ↗ |
| May 20, 2026 | B. Christopher DiSantis Director | ABG Asbury Automotive Group Inc | Buy | 157 | $182.31 | $28.6K Buy | Form 4 ↗ |
| Mar 10, 2026 | B. Christopher DiSantis Director | ABG Asbury Automotive Group Inc | Buy | 500 | $202.30 | $101.2K Buy | Form 4 ↗ |
| Mar 6, 2026 | David W. Hult President & CEO, Director | ABG Asbury Automotive Group Inc | Buy | 3,396 | $205.63 | $698.3K Buy | Form 4/A ↗ |
| Mar 6, 2026 | David W. Hult President & CEO, Director | ABG Asbury Automotive Group Inc | Buy | 1,604 | $204.73 | $328.4K Buy | Form 4/A ↗ |
| Nov 25, 2025 | Jed Milstein SVP & CHRO | ABG Asbury Automotive Group Inc | Sale | 1,132 | $235.26 | $266.3K Sale | Form 4 ↗ |
| Aug 28, 2025 | Maureen F. Morrison Director | ABG Asbury Automotive Group Inc | Sale | 800 | $255.61 | $204.5K Sale | Form 4 ↗ |
| Aug 22, 2025 | Dean Calloway SVP, General Counsel & Sec | ABG Asbury Automotive Group Inc | Sale | 400 | $254.40 | $101.8K Sale | Form 4 ↗ |
| Aug 22, 2025 | Jed Milstein SVP & CHRO | ABG Asbury Automotive Group Inc | Sale | 1,132 | $253.26 | $286.7K Sale | Form 4 ↗ |
| Aug 19, 2025 | Juanita T. James Director | ABG Asbury Automotive Group Inc | Sale | 625 | $244.10 | $152.6K Sale | Form 4 ↗ |
| Jul 30, 2025 | Abrams Capital Management, L.P. 10% owner | ABG Asbury Automotive Group Inc | Buy | 46,952 | $225.16 | $10.6M Buy | Form 4 ↗ |
| Feb 19, 2025 | Daniel Clara Chief Operating Officer | ABG Asbury Automotive Group Inc | Sale | 1,217 | $296.64 | $361.0K Sale | Form 4 ↗ |
| Nov 27, 2024 | Daniel Clara SVP, Operations | ABG Asbury Automotive Group Inc | Sale | 723 | $261.97 | $189.4K Sale | Form 4 ↗ |
| Nov 27, 2024 | Daniel Clara SVP, Operations | ABG Asbury Automotive Group Inc | Sale | 1,127 | $261.20 | $294.4K Sale | Form 4 ↗ |
| Nov 27, 2024 | Daniel Clara SVP, Operations | ABG Asbury Automotive Group Inc | Sale | 2,750 | $260.33 | $715.9K Sale | Form 4 ↗ |
15 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:44 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances